Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a hogh-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

H Goldschmidt, Pieter Sonneveld, FW Cremer, Ronnie van der Holt, P Westveer, I Breitkreutz, A Benner, A Glasmacher, LGD Schmidt-Wolf, H Martin, D Hoelzer, AD Ho, HM Lokhorst

Research output: Contribution to journalArticleAcademicpeer-review

37 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)654-659
Number of pages6
JournalAnnals of Hematology
Publication statusPublished - 2003

Cite this